Pesquisar | MTSocial

Prasad Shinde adicionou um novo artigo Outro
2026-02-04 07:17:58 -

Crigler-Najjar Syndrome Treatment: Orphan Drug Research at 5.60% CAGR to 2032
"Key Drivers Impacting Executive Summary Crigler-Najjar Syndrome Treatment Market Size and Share The global Crigler-Najjar Syndrome treatment market size was valued at USD 150.50 million in 2024 and is expected to reach USD 232.72 million by 2032, at a CAGR of 5.60% during the forecast period The Crigler-Najjar Syndrome Treatment Market report contains...

0 Comentários 0 Compartilhamentos 509 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Sophia Sanjay adicionou um novo artigo Health
2025-11-04 09:07:55 -

The Orphan Drug Imperative: Exploring Regulatory Incentives and Investment Trends Fueling the Rare Disease Segment
The rare disease segment, predominantly served by **orphan drugs**—medications developed to treat conditions affecting a very small patient population—has become a disproportionately powerful engine of innovation and investment within the specialty pharmaceuticals market. This growth is largely fueled by significant **regulatory incentives**, most notably the U.S. Orphan Drug Act...

0 Comentários 0 Compartilhamentos 803 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Shubhangi Fusam adicionou um novo artigo Health
2025-11-18 11:06:49 -

The Orphan Drug Premium: Analyzing the Financial Incentives and Pricing Strategies Driving Innovation in the Duchenne Muscular Dystrophy Market.
The Duchenne Muscular Dystrophy (DMD) market is fundamentally shaped by the economics of rare diseases, operating under the Orphan Drug framework established by legislation like the U.S. Orphan Drug Act. These incentives—extended market exclusivity, tax credits, and accelerated review—are essential to de-risk the massive R&D investment required for a small patient population....

0 Comentários 0 Compartilhamentos 725 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Shiv Mehara adicionou um novo artigo Outro
2025-12-11 04:46:03 -

Alagille Syndrome Treatment Market Size Projected to Reach USD 158.3 Million by 2032
The global Alagille Syndrome Treatment Market focuses on therapies aimed at managing the symptoms and complications of Alagille Syndrome (ALGS), a rare, multi-system genetic disorder caused primarily by mutations in the JAG1 gene. ALGS is characterized by abnormalities in the liver, heart, eyes, skeleton, and kidneys, with the most common and severe manifestation being chronic cholestasis...

0 Comentários 0 Compartilhamentos 786 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!
Shiv Mehara adicionou um novo artigo Outro
2025-12-11 06:31:43 -

Charcot-Marie-Tooth Disease Market Size Projected to Reach USD 5.96 Billion by 2032
The global Charcot-Marie-Tooth Disease Market focuses on the management and development of therapies for CMT, which represents a group of inherited neurological disorders that damage the peripheral nerves, leading to muscle weakness, loss of sensation, and physical impairment, predominantly in the feet, legs, hands, and arms. Currently, the market is characterized primarily by supportive and...

0 Comentários 0 Compartilhamentos 813 Visualizações 0 Anterior

Faça Login para curtir, compartilhar e comentar!